Outcome after neurorehabilitative treatment of stroke: Comparative observational study in Germany and Kazakhstan.

Conditions: I60
I61
I62
I63
I64
Subarachnoid haemorrhage
Intracerebral haemorrhage
Other nontraumatic intracranial haemorrhage
Cerebral infarction
Stroke, not specified as haemorrhage or infarction

Registration Number: DRKS00033827

Lead Sponsor: urija Institut Kliniken Schmieder Allensbach

Brief Summary: Not available

Detailed Description: Not available

Recruitment & Eligibility

Status: Pending

Sex: All

Target Recruitment: 90

Inclusion Criteria

First stroke
- Time since the event: < 4 weeks
- Moderately affected patients based on a Barthel Index >40 and = 70 at study inclusion
- Ability to understand basic instructions and information
- Willingness to participate by the patient or their carer
- Knowledge of the type of stroke (ischaemic / haemorrhagic)

Exclusion Criteria

- Presence of a serious, life-shortening other illness (e.g. cancer, severe heart failure, severe lung disease)
- Presence of a severe psychiatric illness
- Presence of other neurological diseases
- Pain during physical activity (visual analogue scale > 5)
- Gastric tube, percutaneous endoscopic gastrostomy

Study & Design

Study Type: observational

Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Assessments based on the International Classification of Functioning, Disability and Health (ICF): 6-minute walk test (6MinWT); 10-meter walk test (maximum and comfortable walking speed); Berg Balance Scale; Functional Ambulation Categories (FAC); Action Research Arm Test (ARAT) and Bartel Index (BI)

Secondary Outcome Measures

Name	Time	Method
Assessments based on the International Classification of Functioning, Disability and Health (ICF): Cognition with Montreal Cognitive Assessment (MoCA); depression with the Hospital Anxiety and Depression Scale (HADS); Stroke Specific Quality of Life Scale (SS-QOL)and the number and type of therapies and complications.